- Home
- / Mithra
Mithra
Stock Price
€0.2
2024-09-18
Market Capitalization
€14.5 M
2024-09-18
Revenue
€40.2 M
FY, 2023
Mithra Summary
Company Summary
- Overview
- Mithra is a pharmaceutical company focused on the development, manufacturing and commercialisation of proprietary, innovative and differentiated drugs and complex generic products dedicated to female healthcare.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Liège, BE | view all locations
- Website
- http://www.mithra.com/en/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
François Fornieri, Owner, CEO
Jean-Michel Foidart, President of the Scientific advisory board
Erik van Den Eynden, Vice-Chairman, Independent Director
LocationsView all
1 location detected
Liège, Wallonie HQ
Belgium
5 Rue St Georges
Mithra Financials
Summary Financials
- Revenue (FY, 2023)
- €40.2M
- Gross profit (FY, 2023)
- €23.3M
- Net income (FY, 2023)
- (€173.5M)
- Cash (FY, 2023)
- €9.0M
- EBIT (FY, 2023)
- (€128.4M)
- Enterprise value
- $221.5M